IMRX - Immuneering Corp - Ordinary Shares Class A
IEX Last Trade
1.11
-0.050 -4.505%
Share volume: 264,507
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.16
-0.05
-4.31%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-10 | 2022-11-10 | 2023-03-06 | 2023-05-04 | 2023-08-03 | 2023-11-09 | |
| Cash flow financing | 193.111 K | 27.784 K | -17.214 K | -184.677 K | 239.408 K | 28.172 M | 21.448 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -12.281 M | -9.449 M | -10.622 M | -11.749 M | -14.418 M | -10.748 M | -12.027 M | |
| Net income | -12.896 M | -11.527 M | -12.844 M | -13.246 M | -13.604 M | -12.189 M | -12.595 M | |
| Depreciation | 200.628 K | 202.357 K | 204.533 K | 189.275 K | 189.630 K | 193.508 K | 195.784 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 279.614 K | 178.425 K | 70.180 K | 12.417 K | 1.046 K | 0.000 | 0.000 | |
| Investing Cashflow | 12.405 M | 22.154 M | -880.076 K | 8.152 M | 18.972 M | 9.163 M | -23.972 M | |
| Net Borrowings | -134.278 M | -124.061 M | -115.103 M | -103.893 M | -89.488 M | -106.862 M | -96.040 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -115.050 K | -164.997 K | -393.134 K | -69.302 K | -27.993 K | -86.686 K | -57.149 K | |
| Cash Change | 137.771 M | 128.101 M | 117.197 M | 105.525 M | 91.536 M | 108.985 M | 97.243 M |